With the Food and Drug Administration now allowing the over-the-counter purchase of continuous glucose monitors (CGMs)—small ...
Level Zero Health, a female-founded medical device startup that's aiming to break new ground by developing a device for ...
Glucotrack has successfully completed its first in-human clinical study for the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein.
Glucotrack has cleared the first human clinical study of its long-term continuous glucose monitoring implant, designed to ...
The firm is focused on creating implanted continuous glucose monitoring systems for diabetics ... The public offering of Glucotrack reflects continuous attempts to raise money for regulatory approval ...
RUTHERFORD, N.J. - Glucotrack, Inc. (NASDAQ: GCTK), a medical technology company, announced the successful completion of its first in human clinical study for a novel continuous glucose monitoring ...
Goode, PhD, President & Chief Executive Officer of Glucotrack. “With these positive results, the promise of continuous blood glucose monitoring is one step closer to reality.” The prospective single ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results